Privia Health Earns 2026 HFMA MAP Award for Revenue Cycle Excellence
MWN-AI** Summary
Privia Health Group, Inc. (Nasdaq: PRVA) has received the esteemed 2026 MAP (Measure, Apply, Perform) Award for High Performance in Revenue Cycle, as recently announced on March 24, 2026. This accolade, presented by the Healthcare Financial Management Association (HFMA), underscores Privia’s consistent excellence in revenue cycle management, with the organization being recognized for its performance in nine out of the last ten years. The MAP Award is a leading acknowledgment in the healthcare sector, aimed at organizations showcasing outstanding achievement across critical revenue cycle metrics such as net collection rate, accounts receivable performance, denial prevention, and cost to collect.
Melanie Suranto, Senior Vice President of Revenue Cycle Management and Credentialing at Privia Health, commented on the significance of this recognition, attributing it to the company’s robust operations and team collaboration, which provide a seamless financial experience for patients. The award ceremony took place on March 18 at the HFMA Revenue Cycle Conference in Arlington, Texas.
Privia Health’s success can be attributed to a comprehensive, multi-year transformation strategy that incorporated advanced analytics, AI-driven automation, improved provider engagement, and scalable operating models to enhance operational efficiency. This strategic approach has propelled the company to meet and surpass HFMA’s industry-standard revenue cycle benchmarks.
Privia Health operates as one of the largest physician enablement companies in the U.S., influencing over 1,300 physician practices and enhancing the healthcare experiences of around 5.8 million patients. The organization’s commitment to delivering high-value care drives its mission to transform healthcare delivery, aiming for better outcomes, lower costs, and healthier communities. More information can be found at priviahealth.com.
MWN-AI** Analysis
Privia Health Group, Inc. (NASDAQ: PRVA) has achieved significant recognition by earning the prestigious 2026 MAP Award for Revenue Cycle Excellence, marking its sustained performance over the past decade. This award reflects the company’s commitment to operational excellence and showcases its capability to meet and exceed industry-standard benchmarks.
From an investment perspective, Privia Health’s recognition by the Healthcare Financial Management Association (HFMA) signals strong operational health amid the changing landscape of healthcare delivery. With an established presence across 24 states, the company's revenue cycle management expertise speaks volumes about its efficiency and adaptability—qualities essential in today's market turbulent environment.
Privia's multi-faceted transformation strategy emphasizes advanced analytics, AI-enabled automation, and enhanced provider education, positioning it as a leader in revenue cycle innovation. These initiatives not only streamline operations but also bolster the patient experience, adding a layer of competitive advantage as healthcare continues shifting towards value-based care. Moreover, its scalable operating models provide resilience against fluctuations in market demand.
Investors should consider that continued recognition, such as the HFMA award, positions Privia Health favorably in an increasingly competitive sector. The emphasis on technology and patient-centered care aligns with broader industry trends, suggesting robust long-term growth potential. Additionally, the company’s strategy of establishing close partnerships with medical groups and health systems enhances its operational robustness while creating new revenue opportunities.
In summary, Privia Health’s recent accolade underlines its strength in revenue cycle management, making it a compelling candidate for investors seeking exposure in the evolving healthcare space. With a solid foundation in technology and innovative practices, Privia Health is poised for sustained growth, suggesting a favorable outlook for its stock in the coming years.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
ARLINGTON, Va., March 24, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced that its network of affiliated medical groups, collectively Privia Medical Group, has been named a recipient of the 2026 MAP (Measure, Apply, Perform) Award for High Performance in Revenue Cycle, sponsored by the Healthcare Financial Management Association (HFMA).
Privia Health has been recognized by HFMA for its revenue cycle capabilities and performance in nine of the last ten years.
The MAP Award is one of the healthcare industry’s most respected distinctions, highlighting organizations that demonstrate sustained excellence across key revenue cycle metrics, including net collection rate, accounts receivable performance, denial prevention, and cost to collect. As a national award winner, Privia Health met or exceeded industry-standard revenue cycle benchmarks (MAP Keys®) while advancing patient-centered best practices aligned with HFMA’s Healthcare Dollars & Sense® initiative.
“Consistent recognition from HFMA reflects the strength of our revenue cycle operations and the collaboration across our teams to deliver a seamless, patient-centered financial experience,” said Melanie Suranto, Senior Vice President, Revenue Cycle Management and Credentialing at Privia Health. “This achievement is a testament to the discipline, innovation, and commitment of our teams nationwide to deliver value for both clinicians and patients.”
The award was presented on March 18 at the HFMA Revenue Cycle Conference in Arlington, Texas.
Privia Health’s performance was driven by a multi-year transformation strategy focused on:
- Advanced analytics and KPI discipline to drive accountability and transparency
- AI-enabled automation and workflow optimization to improve efficiency and accuracy
- Enhanced provider engagement and education to strengthen front-end performance
- Scalable operating models to support growth across diverse markets
These efforts resulted in strong performance across HFMA’s MAP benchmarks, reinforcing Privia Health’s position as a leader in revenue cycle innovation and execution.
About Privia Health
Privia Health™ is one of the largest physician enablement companies in the United States with a presence in 24 states and the District of Columbia. Privia builds scaled provider networks with primary-care centric medical groups, risk-bearing entities, a physician-led governance structure, and the Privia Platform comprising an extensive suite of technology and service solutions. Privia collaborates with medical groups, health plans and health systems to optimize 1,300+ physician practices, improve the patient experience for 5.8+ million patients, and reward 5,300+ physicians and advanced practitioners for delivering high-value care.
Privia’s mission is to transform healthcare delivery to achieve better outcomes, lower costs, and improve the health of communities and the well-being of providers. For more information, visit priviahealth.com.
Contact
Robert Borchert
SVP, Investor & Corporate Communications
IR@priviahealth.com
817.783.4841
FAQ**
How does Privia Health Group Inc. PRVA plan to maintain its revenue cycle performance excellence following its 2026 MAP Award recognition by HFMA?
What specific AI-enabled automation strategies has Privia Health Group Inc. PRVA implemented to enhance efficiency in its revenue cycle processes?
Can you elaborate on the multi-year transformation strategy that helped Privia Health Group Inc. PRVA achieve strong performance in HFMA's MAP benchmarks?
How does the recognition of Privia Health Group Inc. PRVA as a leader in revenue cycle innovation impact its relationships with healthcare providers and patients?
**MWN-AI FAQ is based on asking OpenAI questions about Privia Health Group Inc. (NASDAQ: PRVA).
NASDAQ: PRVA
PRVA Trading
1.78% G/L:
$21.21 Last:
724,598 Volume:
$20.68 Open:
